Editorial: Protein modifications in epigenetic dysfunctional diseases: mechanisms and potential therapeutic strategies

Jing Ji; Aixin Jing; Ting Geng; Xinhui Ma; Wei Liu; Bin Liu

doi:10.3389/fcell.2023.1216637

Editorial: Protein modifications in epigenetic dysfunctional diseases: mechanisms and potential therapeutic strategies

Front Cell Dev Biol. 2023 May 15:11:1216637. doi: 10.3389/fcell.2023.1216637. eCollection 2023.

Authors

Jing Ji¹, Aixin Jing¹, Ting Geng¹, Xinhui Ma¹, Wei Liu², Bin Liu¹

Affiliations

¹ Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, China.
² School of Molecular Sciences and Biodesign Center for Applied Structural Discovery, Arizona State University, Tempe, AZ, United States.

No abstract available

Keywords: DNA methylation; epigenetic mechanism; epigenetic regulation; epigenetic-related disorders; post-translational modifications (PMTs).

Publication types

Editorial

Grants and funding

This study was funded by the National Natural Science Foundation of China (82273167 and 82104174), Jiangsu Province Basic Research Program Natural Science Foundation (Outstanding Youth Fund Project, BK20220063), the Key Program of Basic Science (Natural Science) of Jiangsu Province (22KJA350001), “Huaguo Mountain Talent Plan” of Lianyungang City (Innovative Talents BL), Qing Lan Project of Jiangsu Universities (Outstanding young backbone teachers, JJ), Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening (HY202103), Priority Academic Program Development of Jiangsu Higher Education Institutions.